U.S. FDA Approves Expanded Label For Astellas' IZERVAYTM (Avacincaptad Pegol Intravitreal Solution) For Geographic Atrophy
IZERVAY dosing approved beyond 12 monthsTOKYO, Feb. 12, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Ok ...
Ocular Melanoma Epidemiology Forecast Market Report 2020-2034: Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan
The "Ocular Melanoma - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.The report delivers an in-depth understanding of ocular melanoma, historical and ...
ophthalmologytimes2d
4DMT announces positive 52-week data from phase 2b cohort of PRISM wet AMD study
PRISM evaluates 4D-150, a potential backbone therapy designed to provide multi-year sustained delivery of anti-VEGF ...
ophthalmologyadvisor8h
Optomap Green-Channel Intensity Correlates With Choroidal Tumor Thickness
Optomap green-channel lesion intensity correlates with ultrasonographic choroidal tumor thickness, according to research.
7MM Myopic Macular Degeneration (MMD) Epidemiology Forecast Report 2020-2034
The "Myopic Macular Degeneration (MMD) - Epidemiology Forecast - 2034" report has been added to ResearchAndMarkets.com's offering.The report delivers an in-depth understanding of Myopic Macular ...
Eye Disease Focused 4D Molecular Therapeutics Lays Out 52-Week Results From Wet AMD Study
D Molecular Therapeutics reported 52-week Phase 2b data for 4D-150 in wet AMD, showing sustained visual acuity improvements.
Medscape6d
Guanfacine Treatment for ADHD Increases Corneal Aberrations in Kids and Adolescents
Guanfacine used for treating ADHD in children and adolescents increases corneal aberrations at 6 months but does not affect the retina, choroid, refraction, or optic nerve.
ophthalmologytimes6d
Study finds faricimab effective for nAMD patients unresponsive to other anti-VEGF treatments
This research team evaluated the effectiveness of switching patients to faricimab treatment by assessing their outcomes after ...
Leerink Partners Upgrades Regeneron Pharmaceuticals (NASDAQ:REGN) to Outperform
Leerink Partners upgraded shares of Regeneron Pharmaceuticals (NASDAQ:REGN – Free Report) from a market perform rating to an ...
optometryadvisor5d
Atropine Treatment Maintains Choroidal Thickness Stability
Atropine therapy has a direct treatment effect on choroidal thickness, which cannot be fully explained by axial length or SER changes.